Patients’ Views of Treatment‐Focused Genetic Testing (TFGT): Some Lessons for the Mainstreaming of BRCA1 and BRCA2 Testing
Authors:
Open Access
- 11 May 2018
- journal article
- research article
- Published by Wiley in Journal of Genetic Counseling
- Vol. 27 (6) , 1459-1472
Abstract
This paper explores patients’ views and experiences of undergoing treatment‐focused BRCA1 and BRCA2 genetic testing (TFGT), either offered following triaging to clinical genetics (breast cancer) or as part of a mainstreamed care pathway in oncology (ovarian cancer). Drawing on 26 in‐depth interviews with patients with breast or ovarian cancer who had undergone TFGT, this retrospective study examines patients’ views of genetic testing at this point in their care pathway, focusing on issues, such as initial response to the offer of testing, motivations for undergoing testing, and views on care pathways. Patients were amenable to the incorporation of TFGT at an early stage in their cancer care irrespective of (any) prior anticipation of having a genetic test or family history. While patients were glad to have been offered TFGT as part of their care, some questioned the logic of the test's timing in relation to their cancer treatment. Crucially, patients appeared unable to disentangle the treatment role of TFGT from its preventative function for self and other family members, suggesting that some may undergo TFGT to obtain information for others rather than for self.Keywords
Funding Information
- Breast Cancer Now (2016MayPR700)
- Breast Cancer Now (2016MayPR700)
This publication has 55 references indexed in Scilit:
- BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study GroupJournal of Clinical Oncology, 2012
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian CancerNew England Journal of Medicine, 2012
- Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancerSupportive Care in Cancer, 2012
- Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancerGynecologic Oncology, 2011
- The role of BRCA mutation testing in determining breast cancer therapyNature Reviews Clinical Oncology, 2010
- Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agendaBreast Cancer Research, 2008
- On doing ‘being ordinary’: women's accounts of BRCA testing and maternal responsibilityNew Genetics and Society, 2007
- Qualitative Data Analysis for Health Services Research: Developing Taxonomy, Themes, and TheoryHealth Services Research, 2007
- Short term psychological distress in patients actively approached for genetic counselling after diagnosis of breast cancerEuropean Journal of Cancer, 2006
- Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40European Journal of Cancer Care, 2005